Chih-Peng Lin, Shu-Hui Wu, Tzu-Yin Lin, Chia-Hui Chu, Leu-Wei Lo, Ching-Chuan Kuo, . . . Dong-Ming Huang. (2023). Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death. Elsevier.
Chicago Style (17th ed.) CitationChih-Peng Lin, et al. Lysosomal-targeted Doxorubicin Delivery Using RBC-derived Vesicles to Overcome Drug-resistant Cancer Through Mitochondrial-dependent Cell Death. Elsevier, 2023.
MLA (9th ed.) CitationChih-Peng Lin, et al. Lysosomal-targeted Doxorubicin Delivery Using RBC-derived Vesicles to Overcome Drug-resistant Cancer Through Mitochondrial-dependent Cell Death. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.